br 1

PRL-3 Inhibitor I (BR-1) 是 PRL-3 抑制剂，IC50=0.9 μM。它在细胞检测中显示降低侵袭性。

NY-BR-1 p904 A2 acetate(347142-73-8 free base) 对这种 NY-BR-1 表位 (p904) 特异的 T 细胞克隆可以识别表达 NY-BR-1 的乳腺肿瘤细胞。

OA-Br-1 是口服活性的PTP1B选择性抑制剂，IC50值为7.08 μM。它能够诱导细胞凋亡 (apoptosis) 并且具有广谱的抗癌细胞增殖活性。OA-Br-1 通过PTP1B/PI3K/AKT 信号通路在体内外对抗乳腺癌。

T-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1.

(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T67021，CAS号为 313369-26-5。

(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T67022，CAS号为 313369-25-4。

(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T67023，CAS号为 313368-85-3。

Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTAC degrader, specifically PROTAC B-Raf degrader 1, which exhibits anti-cancer activity[1].

Cyclohexane-PEG1-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

N-Ethylpropionamide-PEG1-Br is a polyethylene glycol (PEG) derived PROTAC linker utilized for the synthesis of Proteolysis Targeting Chimeras (PROTACs).

N-Ethyl-N-methylpropionamide-PEG1-Br is a PEG-derived PROTAC linker suitable for the synthesis of PROTACs.

Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br 作为一种Drug-linker conjugates for ADC，主要用于抗CD40抗体活性分子偶联物 (ADCs) 的合成, 充当反应试剂。

Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br 为ADC linker，适用于ABBV-154、ABBV-927及ABBV-368或相似化合物的合成。

(3aS,7S,9bR)-4,5-dihydroxy-7,9b-dimethyl-dodecahydronaphtho[1,2-c]furan-1-one 是一种从微生物中分离到的萜类天然产物。

N-Ethylacetamide-PEG1-Br 是一种 PROTAC linker，归类为 PEG 类，可用于合成 PROTAC 分子。

A2AR/A2BR antagonist 1 (compound 7ai) 对A2AR和A2BR表现出双重拮抗效应，其IC50值分别为11.2 nM和6.4 nM。A2AR/A2BR antagonist 1 能够促进T细胞介导的癌细胞死亡。

5-(11bR)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-5H-dibenz[b,f]azepine 是一种有用的有机化合物，可用于生命科学领域的相关研究，其产品编号为 T64437。

(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,8dR,9aR,9bR)-2,9b-Dihydroxy-4a,6a-dimethylhexadecahydro-1H-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-7(7aH)-one 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T67508，CAS号为 82543-16-6。

Anti-BRCA1 Antibody (BR64) 为小鼠IgG1, κ 嵌合抗体，专门针对BRCA1(人源)。该抗体的同型对照为 MouseIgG1kappa, Isotype Control。

Anti-Mouse IFN gamma Antibody (MP6-B1-BR)是靶向小鼠 IFN-γ 的单克隆抗体抑制剂，可用于免疫学研究。

GBR 12783 can improve memory performance and increase hippocampal acetylcholine release in rats. GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively.

GBR 12935 dihydrochloride (GBR 12935) 是一种多巴胺再吸收抑制剂。

GBR-12935 is a piperazine derivative. It is an effective and selective dopamine reuptake inhibitor. GBR-12935 is now widely used in animal research into Parkinson's disease and the dopamine pathways in the brain.

BIBR 1087 SE (Desethyl Dabigatran Etexilate) 是一种 dabigatran etexilate 的代谢物。